Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||
| Net Income | -382 | -973 |
| Depreciation Amortization | 2 | 1 |
| Accounts receivable | -150 | N/A |
| Other Working Capital | -183 | 182 |
| Other Operating Activity | 151 | 0 |
| Operating Cash Flow | $-564 | $-790 |
| Cash Flows From Investing Activities | ||
| PPE Investments | N/A | -7 |
| Investing Cash Flow | $N/A | $-7 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 0 | 1,050 |
| Financing Cash Flow | $N/A | $1,050 |
| Exchange Rate Effect | 18 | 19 |
| Beginning Cash Position | 734 | 462 |
| End Cash Position | 188 | 734 |
| Net Cash Flow | $-546 | $272 |
| Free Cash Flow | ||
| Operating Cash Flow | -564 | -790 |
| Free Cash Flow | -564 | -790 |